Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 12/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 5/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.41 |
| ▸ | TSHR | P16473 | 4/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | CRHBP | P24387 | 1/20 | 0.35 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.35 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4449767 | 1.00 | AHR (0.61) | AHRMAPK1CYP3A4ALDH1A1HPGD | |
| SCHEMBL29432665 | 0.88 | AHR (0.61) | AHRMAPK1CYP3A4ALDH1A1HPGD | |
| SCHEMBL4458352 | 0.88 | AHR (0.61) | AHRMAPK1CYP3A4ALDH1A1HPGD | |
| SCHEMBL4446978 | 0.83 | AHR (0.55) | AHRMAPK1CYP3A4ALDH1A1HPGD | |
| SCHEMBL30035407 | 0.83 | AHR (0.55) | AHRMAPK1CYP3A4ALDH1A1HPGD | |
| SCHEMBL29455135 | 0.81 | AHR (0.52) | AHRMAPK1CYP3A4ALDH1A1HSD17B10 | |
| SCHEMBL4450440 | 0.81 | AHR (0.52) | AHRMAPK1CYP3A4ALDH1A1HSD17B10 | |
| SCHEMBL30035000 | 0.80 | CYP3A4 (0.61) | AHRMAPK1CYP3A4ALDH1A1HPGD | |
| SCHEMBL4456805 | 0.80 | CYP3A4 (0.61) | AHRMAPK1CYP3A4ALDH1A1HPGD | |
| SCHEMBL2934408 | 0.79 | HSD17B10 (0.52) | AHRMAPK1CYP3A4ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116893235-A | Method and kit for determining polychlorinated biphenyl and multi-class brominated flame retardant residues in traditional Chinese medicine | 江苏省食品药品监督检验研究院(江苏省食品质量安全监控中心) | 2023-10-17 | — | — | CN | claimed |
| US-20220351865-A1 | METHODS OF BIOLOGICAL AGE EVALUATION AND SYSTEMS USING SUCH METHODS | GERO PTE. LTD. (SG) | 2022-11-03 | — | — | US | claimed |
| CN-114394680-A | Application of microbial agent in degradation of various halogenated organic pollutants | 河南科技大学 | 2022-04-26 | — | — | CN | claimed |
| US-20230330725-A1 | VOLATILIZATION AND OXIDATION OF ORGANIC WASTE | NATIONAL BANK OF CANADA (CA) | 2023-10-19 | — | — | US | disclosed |
| CN-116893235-A | Method and kit for determining polychlorinated biphenyl and multi-class brominated flame retardant residues in traditional Chinese medicine | 江苏省食品药品监督检验研究院(江苏省食品质量安全监控中心) | 2023-10-17 | — | — | CN | disclosed |
| US-20230047816-A1 | PFKFB3 INHIBITORS AND THEIR USES | GERO PTE. LTD. (SG) | 2023-02-16 | — | — | US | disclosed |
| US-20220351865-A1 | METHODS OF BIOLOGICAL AGE EVALUATION AND SYSTEMS USING SUCH METHODS | GERO PTE. LTD. (SG) | 2022-11-03 | — | — | US | disclosed |
| CN-114634886-A | Multifunctional microbial agent capable of degrading various halogenated organic pollutants simultaneously | 河南科技大学 | 2022-06-17 | — | — | CN | disclosed |
| CN-114394680-A | Application of microbial agent in degradation of various halogenated organic pollutants | 河南科技大学 | 2022-04-26 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230047816-A1 | PFKFB3 INHIBITORS AND THEIR USES | PFKFB3, PFKFB4, PFKFB1 | AHR 3353/4885MAPK1 1468/4885CYP3A4 2539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.